These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 24837144)
21. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786 [TBL] [Abstract][Full Text] [Related]
22. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus. Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171 [TBL] [Abstract][Full Text] [Related]
23. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. Noto H; Goto A; Tsujimoto T; Noda M PLoS One; 2012; 7(3):e33411. PubMed ID: 22448244 [TBL] [Abstract][Full Text] [Related]
24. Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies. Salari-Moghaddam A; Sadeghi O; Keshteli AH; Larijani B; Esmaillzadeh A Osteoporos Int; 2019 Jun; 30(6):1167-1173. PubMed ID: 30927035 [TBL] [Abstract][Full Text] [Related]
25. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis. Shuai Y; Li C; Zhou X Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719 [TBL] [Abstract][Full Text] [Related]
26. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis. Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493 [TBL] [Abstract][Full Text] [Related]
27. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis. Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254 [TBL] [Abstract][Full Text] [Related]
28. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis. Cheng Y; Chen Y; Zhou C; Shen L; Tu F; Xu J; Liu C Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):73-81. PubMed ID: 31300371 [TBL] [Abstract][Full Text] [Related]
29. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556 [TBL] [Abstract][Full Text] [Related]
30. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis. Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557 [TBL] [Abstract][Full Text] [Related]
31. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis. Tian S; Lei HB; Liu YL; Chen Y; Dong WG Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073 [TBL] [Abstract][Full Text] [Related]
32. Guo Y; Liu W; Wu J J Cancer Res Ther; 2016 Dec; 12(Supplement):C229-C232. PubMed ID: 28230023 [TBL] [Abstract][Full Text] [Related]
33. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis. Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158 [TBL] [Abstract][Full Text] [Related]
34. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies. Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548 [TBL] [Abstract][Full Text] [Related]
35. Association of metformin use and cancer incidence: a systematic review and meta-analysis. O'Connor L; Bailey-Whyte M; Bhattacharya M; Butera G; Hardell KNL; Seidenberg AB; Castle PE; Loomans-Kropp HA J Natl Cancer Inst; 2024 Apr; 116(4):518-529. PubMed ID: 38291943 [TBL] [Abstract][Full Text] [Related]
36. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis. Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848 [TBL] [Abstract][Full Text] [Related]
37. Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies. Zhang Y; Zhang Y; Shi X; Han J; Lin B; Peng W; Mei Z; Lin Y Diabet Med; 2022 Jun; 39(6):e14821. PubMed ID: 35213749 [TBL] [Abstract][Full Text] [Related]
38. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients. Tian J; Liang Y; Qu P Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843 [TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol. Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690 [TBL] [Abstract][Full Text] [Related]
40. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]